US 7,485,635 B2
	Short-acting benzodiazepines
Paul L. Feldman, Research Triangle Park, N.C. (US); David Kendall Jung, Research Triangle Park, N.C. (US); Istvan Kaldor, Research Triangle Park, N.C. (US); Gregory J. Pacofsky, Research Triangle Park, N.C. (US); Jeffrey A. Stafford, Research Triangle Park, N.C. (US); and Jeffrey H. Tidwell, Research Triangle Park, N.C. (US)
Assigned to CeNes Limited, Cambridge (United Kingdom)
Filed on Dec. 05, 2006, as Appl. No. 11/634,788.
Application 11/634788 is a continuation of application No. 09/980680, filed on Oct. 31, 2001, granted, now 7,160,880.
Application 09/980680 is a continuation of application No. PCT/US00/13134, filed on May 12, 2000.
Claims priority of application No. 9911152.8 (GB), filed on May 14, 1999.
Prior Publication US 2007/0093475 A1, Apr. 26, 2007
This patent is subject to a terminal disclaimer.
Int. Cl. A61P 25/20 (2006.01); A61K 31/55 (2006.01); C07D 487/04 (2006.01)

U.S. Cl. 514—220  [540/562]

7 Claims

1. Methyl 3-[4S-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazepine-4-yl]propanoate or a pharmaceutically acceptable salt of solvate thereof.